Appropriateness criteria of FDG PET/CT in oncology

(18)Fluorine-2-fluoro-2-Deoxy-d-glucose ((18)F-FDG) positron emission tomography/computerized tomography (PET/CT) is a well-established functional imaging method widely used in oncology. In this article, we have incorporated the various indications for (18)FDG PET/CT in oncology based on available e...

Descripción completa

Detalles Bibliográficos
Autores principales: Agrawal, Archi, Rangarajan, Venkatesh
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2015
Materias:
Imaging in Oncology: Recent Advances
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4419439/
https://www.ncbi.nlm.nih.gov/pubmed/25969632
http://dx.doi.org/10.4103/0971-3026.155823
_version_ 1782369573465489408
author Agrawal, Archi
Rangarajan, Venkatesh
author_facet Agrawal, Archi
Rangarajan, Venkatesh
author_sort Agrawal, Archi
collection PubMed
description (18)Fluorine-2-fluoro-2-Deoxy-d-glucose ((18)F-FDG) positron emission tomography/computerized tomography (PET/CT) is a well-established functional imaging method widely used in oncology. In this article, we have incorporated the various indications for (18)FDG PET/CT in oncology based on available evidence and current guidelines. Growing body of evidence for use of (18)FDG PET/CT in select tumors is also discussed. This article attempts to give the reader an overview of the appropriateness of using (18)F-FDG PET/CT in various malignancies.
format Online
Article
Text
id pubmed-4419439
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher Medknow Publications & Media Pvt Ltd
record_format MEDLINE/PubMed
spelling pubmed-44194392015-05-12 Appropriateness criteria of FDG PET/CT in oncology Agrawal, Archi Rangarajan, Venkatesh Indian J Radiol Imaging Imaging in Oncology: Recent Advances (18)Fluorine-2-fluoro-2-Deoxy-d-glucose ((18)F-FDG) positron emission tomography/computerized tomography (PET/CT) is a well-established functional imaging method widely used in oncology. In this article, we have incorporated the various indications for (18)FDG PET/CT in oncology based on available evidence and current guidelines. Growing body of evidence for use of (18)FDG PET/CT in select tumors is also discussed. This article attempts to give the reader an overview of the appropriateness of using (18)F-FDG PET/CT in various malignancies. Medknow Publications & Media Pvt Ltd 2015 /pmc/articles/PMC4419439/ /pubmed/25969632 http://dx.doi.org/10.4103/0971-3026.155823 Text en Copyright: © Indian Journal of Radiology and Imaging http://creativecommons.org/licenses/by-nc-sa/3.0 This is an open-access article distributed under the terms of the Creative Commons Attribution-Noncommercial-Share Alike 3.0 Unported, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Imaging in Oncology: Recent Advances
Agrawal, Archi
Rangarajan, Venkatesh
Appropriateness criteria of FDG PET/CT in oncology
title Appropriateness criteria of FDG PET/CT in oncology
title_full Appropriateness criteria of FDG PET/CT in oncology
title_fullStr Appropriateness criteria of FDG PET/CT in oncology
title_full_unstemmed Appropriateness criteria of FDG PET/CT in oncology
title_short Appropriateness criteria of FDG PET/CT in oncology
title_sort appropriateness criteria of fdg pet/ct in oncology
topic Imaging in Oncology: Recent Advances
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4419439/
https://www.ncbi.nlm.nih.gov/pubmed/25969632
http://dx.doi.org/10.4103/0971-3026.155823
work_keys_str_mv AT agrawalarchi appropriatenesscriteriaoffdgpetctinoncology
AT rangarajanvenkatesh appropriatenesscriteriaoffdgpetctinoncology

Ejemplares similares